WG
GDRX icon

Winton Group’s GoodRx Holdings GDRX Stock Holding History

Winton Group’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-29,454
Closed -$147K – 840
2025
Q2 		$147K Sell
29,454
-37,407
-56% -$162K 0.01% 767
2025
Q1 		$295K Buy
+66,861
New +$314K 0.02% 581
2024
Q4 		– Sell
-18,934
Closed -$131K – 676
2024
Q3 		$131K Buy
+18,934
New +$149K 0.01% 587
2024
Q1 		– Sell
-31,688
Closed -$212K – 706
2023
Q4 		$212K Sell
31,688
-6,124
-16% -$34.5K 0.02% 628
2023
Q3 		$213K Buy
37,812
+6,732
+22% +$44.9K 0.02% 641
2023
Q2 		$172K Buy
+31,080
New +$167K 0.01% 680

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Winton Group's GDRX Position: Q3 2025 in Review

Winton Group sold out of GoodRx Holdings (GDRX) in Q3 2025, closing a stake of 29,454 shares — an estimated $147K sold.

Winton Group first reported a position in GDRX in Q2 2023 and held it in 6 quarters. The position peaked at $295K in Q1 2025. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.

  • Winton Group reported no remaining GoodRx Holdings position as of Q3 2025 after selling out during the quarter.
  • Winton Group sold 29,454 GoodRx Holdings shares in Q3 2025, an estimated $147K.
  • Winton Group first reported a position in GoodRx Holdings in Q2 2023 and held it in 6 quarters.
  • Winton Group's GoodRx Holdings position peaked at $295K in Q1 2025.
  • 161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.

Based on Winton Group's 13F filing for Q3 2025, filed 13 Nov 2025.